Find your path to Chris
799 people in our graph can introduce you to Chris.
Sign up to see every warm intro you have to Chris
- Paths you didn't know you had: your email and LinkedIn already hold routes to Chris. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Chris Sullivan has been Avalo's CFO since February 2022, having previously served as its Chief Accounting Officer and Interim CFO. He was earlier Corporate Controller at Sucampo Pharmaceuticals and OpGen and a Senior Manager at Ernst & Young.
Experience
- Avalo TherapeuticsChief Financial Officer at Avalo Therapeuticscurrent2022 — present
- Avalo TherapeuticsChief Accounting Officer2021 — 2022
- Avalo TherapeuticsChief Financial Officer - Interim2020 — 2021Rockville, Maryland
- Avalo TherapeuticsVP of Finance other escalating roles2018 — 2020Rockville, Maryland, United States
- Sucampo Pharmaceuticals, Inc.Corporate Controller2017 — 2018Gaithersburg, Maryland
- OpGen, Inc.Corporate Controller2015 — 2017Gaithersburg, MD
- EYSr. Manager2005 — 2015Baltimore, Maryland
Skills & more
SEC Financial Reporting2Financial Analysis3Accounting3
- CPA — AICPA
From Chris's professional profile.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Garry A. Neil
Chief Executive Officer at Avalo Therapeutics
Gilla Kaplan
Board Member at Avalo Therapeutics
Jennifer Riley
Chief Strategy Officer at Avalo Therapeutics
Kathleen Cohen
Senior Vice President, Clinical Development Operations at Avalo Therapeutics
Frequently asked questions
- Who is Chris Sullivan?
- Chris Sullivan has been Avalo's CFO since February 2022, having previously served as its Chief Accounting Officer and Interim CFO. He was earlier Corporate Controller at Sucampo Pharmaceuticals and OpGen and a Senior Manager at Ernst & Young.
- Where does Chris Sullivan work?
- Chris Sullivan is Chief Financial Officer at Avalo Therapeutics.
- Where did Chris Sullivan go to school?
- Chris Sullivan studied at University of Maryland (Bachelor's degree of Accounting and Finance, Accounting and Finance).
Same school
Also attended University of Maryland503
Katrina PagliaChief Legal Officer at Pantera CapitalSujal PatelStrategic Director at Madrona Venture GroupDaniel DemmerInvestor at OpenView Venture PartnersDan RochkindCFO at Lerer HippeauAaron EpsteinGeneral Partner at Y CombinatorKevin NiechenInvestment Team at 8VC
+ 497 more
Shared employers
Also worked at Avalo Therapeutics16
Aaron KantoffManaging Partner at Scion Life SciencesSamantha TruexInvestor at Avalo TherapeuticsMittie DoyleChief Medical Officer at Avalo TherapeuticsPaul VarkiChief Legal Officer at Avalo TherapeuticsJennifer RileyChief Strategy Officer at Avalo TherapeuticsTaylor BoydChief Business Officer at Avalo Therapeutics
+ 10 more
Also worked at Sucampo Pharmaceuticals, Inc.2
Also worked at OpGen, Inc.2
Also worked at EY2,000
Tyler WilsonSenior Accountant at Felicis VenturesSandra SchwarzerInvestor at Index VenturesTorjus Randeberg FalkangerInvestor at InvestinorAngela ToyPartner & COO at Golden Gate VenturesHark AhluwaliaAssociate at RevolutionGiuseppe Brambilla di CivesioOperating Advisor at P101 Ventures
+ 1,994 more




























